Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

Similar articles for PubMed (Select 24071015)

1.

Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.

Zhang X, Dong Y, Ti H, Zhao J, Wang Y, Li T, Zhang B.

Hum Pathol. 2013 Nov;44(11):2571-80. doi: 10.1016/j.humpath.2013.07.002. Epub 2013 Sep 24.

PMID:
24071015
2.

Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.

Garg K, Shih K, Barakat R, Zhou Q, Iasonos A, Soslow RA.

Am J Surg Pathol. 2009 Dec;33(12):1869-77. doi: 10.1097/PAS.0b013e3181bc9866.

PMID:
19898223
3.

PIK3CA mutations in endometrial carcinomas in Chinese women: phosphatidylinositol 3'-kinase pathway alterations might be associated with favorable prognosis.

Dong Y, Yang X, Wong O, Zhang X, Liang Y, Zhang Y, Wong W, Nong L, Liao Q, Li T.

Hum Pathol. 2012 Aug;43(8):1197-205. doi: 10.1016/j.humpath.2011.08.021. Epub 2011 Dec 30.

PMID:
22209294
4.

[MicroRNA expression signature profile and its clinical significance in endometrioid carcinoma].

Wang Y, Adila S, Zhang X, Dong Y, Li W, Zhou M, Li T.

Zhonghua Bing Li Xue Za Zhi. 2014 Feb;43(2):88-94. Chinese.

PMID:
24742567
5.

Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.

Xiong Y, Dowdy SC, Xue A, Shujuan J, Eberhardt NL, Podratz KC, Jiang SW.

Gynecol Oncol. 2005 Mar;96(3):601-9.

PMID:
15721400
6.

Up-regulation of DNA methyltransferase 3B expression in endometrial cancers.

Jin F, Dowdy SC, Xiong Y, Eberhardt NL, Podratz KC, Jiang SW.

Gynecol Oncol. 2005 Feb;96(2):531-8.

PMID:
15661247
7.

Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis.

Zheng J, Wu C, Lin Z, Guo Y, Shi L, Dong P, Lu Z, Gao S, Liao Y, Chen B, Yu F.

FEBS J. 2014 Jan;281(1):88-103. doi: 10.1111/febs.12574. Epub 2013 Nov 5.

PMID:
24138392
8.

MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.

Lee H, Park CS, Deftereos G, Morihara J, Stern JE, Hawes SE, Swisher E, Kiviat NB, Feng Q.

World J Surg Oncol. 2012 Aug 27;10:174.

9.
10.

Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type.

Ruiz I, Martín-Arruti M, Lopez-Lopez E, Garcia-Orad A.

Gynecol Oncol. 2014 Jul;134(1):20-3. doi: 10.1016/j.ygyno.2014.04.053. Epub 2014 May 9.

PMID:
24814467
11.

Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.

Girault I, Tozlu S, Lidereau R, Bièche I.

Clin Cancer Res. 2003 Oct 1;9(12):4415-22.

12.

Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.

Shih KK, Garg K, Levine DA, Kauff ND, Abu-Rustum NR, Soslow RA, Barakat RR.

Gynecol Oncol. 2011 Oct;123(1):88-94. doi: 10.1016/j.ygyno.2011.06.005. Epub 2011 Jul 13.

PMID:
21742371
13.

Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma.

Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R.

BMC Cancer. 2012 Aug 24;12:369. doi: 10.1186/1471-2407-12-369.

14.

Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.

Peiró G, Peiró FM, Ortiz-Martínez F, Planelles M, Sánchez-Tejada L, Alenda C, Ceballos S, Sánchez-Payá J, Laforga JB.

Hum Pathol. 2013 Feb;44(2):218-25. doi: 10.1016/j.humpath.2012.05.008. Epub 2012 Sep 3.

PMID:
22955108
15.

Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.

Catasus L, Gallardo A, Cuatrecasas M, Prat J.

Mod Pathol. 2009 Apr;22(4):522-9. doi: 10.1038/modpathol.2009.5. Epub 2009 Feb 20.

16.

ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma.

Romero-Pérez L, López-García MÁ, Díaz-Martín J, Biscuola M, Castilla MÁ, Tafe LJ, Garg K, Oliva E, Matias-Guiu X, Soslow RA, Palacios J.

Mod Pathol. 2013 Nov;26(11):1514-24. doi: 10.1038/modpathol.2013.93. Epub 2013 Jun 7.

17.

Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.

Romero-Pérez L, Castilla MÁ, López-García MÁ, Díaz-Martín J, Biscuola M, Ramiro-Fuentes S, Oliva E, Matias-Guiu X, Prat J, Cano A, Moreno-Bueno G, Palacios J.

Hum Pathol. 2013 Feb;44(2):244-54. doi: 10.1016/j.humpath.2012.05.013. Epub 2012 Sep 10.

PMID:
22974476
18.

microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.

Devor EJ, Hovey AM, Goodheart MJ, Ramachandran S, Leslie KK.

Oncol Rep. 2011 Oct;26(4):995-1002. doi: 10.3892/or.2011.1372. Epub 2011 Jul 1.

19.

beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.

Moreno-Bueno G, Gamallo C, Pérez-Gallego L, de Mora JC, Suárez A, Palacios J.

Diagn Mol Pathol. 2001 Jun;10(2):116-22.

PMID:
11385321
20.

Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.

Nguyen T, Kuo C, Nicholl MB, Sim MS, Turner RR, Morton DL, Hoon DS.

Epigenetics. 2011 Mar;6(3):388-94. Epub 2011 Mar 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk